Elutia (ELUT) Gains from Sales and Divestitures (2022 - 2026)
Elutia recorded quarterly Gains from Sales and Divestitures of $113426.0 in Q1 2026, down 86.19% quarter-over-quarter from $821197.0 in Q4 2025, and down 26.52% year-over-year from $154358.0 in Q1 2025.
Elutia's Gains from Sales and Divestitures history runs 5 years deep, the most recent figure standing at $113426.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 26.52% year-over-year to $113426.0; the TTM figure through Mar 2026 stood at $113426.0 (down 26.52% YoY), while the FY2025 annual figure was $821197.0, down 27.31% from the prior year.
- Gains from Sales and Divestitures came in at $113426.0 for Q1 2026 at Elutia, down from $821197.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.1 million in Q4 2024 to a low of $12070.0 in Q1 2023.
- A 5-year average of $308715.9 and a median of $154358.0 in 2025 frame the typical range for Gains from Sales and Divestitures.
- Across the five-year window, Gains from Sales and Divestitures tumbled 85.28% in 2023 and soared 2765.74% in 2024, its largest moves.
- Elutia's Gains from Sales and Divestitures stood at $238617.0 in 2022, then slumped by 68.15% to $75996.0 in 2023, then soared by 1386.59% to $1.1 million in 2024, then decreased by 27.31% to $821197.0 in 2025, then plunged by 86.19% to $113426.0 in 2026.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $113426.0, $821197.0, and $707269.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113,426.00 |
| Mar 31, 2026 | 113,426.00 |
| Dec 31, 2025 | 821,197.00 |
| Dec 31, 2025 | 821,197.00 |
| Sep 30, 2025 | 707,269.00 |
| Sep 30, 2025 | 707,269.00 |
| Jun 30, 2025 | 327,634.00 |
| Jun 30, 2025 | 327,634.00 |
| Mar 31, 2025 | 154,358.00 |
| Mar 31, 2025 | 154,358.00 |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 303,844.00 |
| Jun 30, 2024 | 303,844.00 |
| Mar 31, 2024 | 12,968.00 |
| Mar 31, 2024 | 12,968.00 |
| Dec 31, 2023 | 75,996.00 |
| Dec 31, 2023 | 75,996.00 |
| Sep 30, 2023 | 35,044.00 |
| Sep 30, 2023 | 35,044.00 |
| Jun 30, 2023 | 34,994.00 |
| Jun 30, 2023 | 34,994.00 |
| Mar 31, 2023 | 12,070.00 |
| Mar 31, 2023 | 12,070.00 |
| Dec 31, 2022 | 238,617.00 |
| Dec 31, 2022 | 238,617.00 |
| Sep 30, 2022 | 238,142.00 |
| Sep 30, 2022 | 238,142.00 |
| Jun 30, 2022 | 19,347.00 |
| Jun 30, 2022 | 19,347.00 |
| Mar 31, 2022 | 19,247.00 |
| Mar 31, 2022 | 19,247.00 |